Literature DB >> 11117586

Effect of L-NMMA on postprandial transient lower esophageal sphincter relaxations in healthy volunteers.

D P Hirsch1, M M Tiel-Van Buul, G N Tytgat, G E Boeckxstaens.   

Abstract

In a previous study we showed that nitric oxide (NO) synthesis inhibition by NG-monomethyl-L-arginine (L-NMMA) reduced the number of transient lower esophageal sphincter relaxations (TLESRs) triggered by gastric balloon distention. The role of NO in postprandial TLESRs and gastroesophageal reflux, however, is unknown. Therefore, we studied the effect of L-NMMA on meal-induced TLESRs and reflux episodes with simultaneous recording of esophageal peristalsis, intraesophageal and intragastric pH, and gastric emptying in healthy volunteers. Ingestion of a solid meal resulted in an increase in TLESRs [8.5 (6.3-11.0) 60 min] which was significantly inhibited by L-NMMA [6.0 (4.0-8.8) 60 min, P < 0.05]. In addition, the total number of reflux episodes was reduced. L-NMMA had no effect on intragastric meal distribution and gastric emptying, but attenuated the postprandial increase in intragastric pH. These results confirm the involvement of NO in the neurocircuitry underlying the triggering of TLESRs. The reduction in reflux by L-NMMA has to be confirmed in patients with gastroesophageal reflux disease. NO may be involved in the regulation of gastric acid secretion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11117586     DOI: 10.1023/a:1005611221617

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  42 in total

1.  Microvascular specializations promoting rapid interstitial solute dispersion in nucleus tractus solitarius.

Authors:  P M Gross; K M Wall; J J Pang; S W Shaver; D S Wainman
Journal:  Am J Physiol       Date:  1990-12

2.  Endogenous nitric oxide as a mediator of gastric mucosal vasodilatation during acid secretion.

Authors:  J M Pique; J V Esplugues; B J Whittle
Journal:  Gastroenterology       Date:  1992-01       Impact factor: 22.682

3.  Atropine inhibits gastric distension and pharyngeal receptor mediated lower oesophageal sphincter relaxation.

Authors:  R K Mittal; C Chiareli; J Liu; R H Holloway; W Dixon
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

4.  Effect of morphine on gastroesophageal reflux and transient lower esophageal sphincter relaxation.

Authors:  R Penagini; P A Bianchi
Journal:  Gastroenterology       Date:  1997-08       Impact factor: 22.682

5.  Role of nitric oxide in regulation of gastric acid secretion in rats: effects of NO donors and NO synthase inhibitor.

Authors:  S Kato; M Kitamura; R P Korolkiewicz; K Takeuchi
Journal:  Br J Pharmacol       Date:  1998-03       Impact factor: 8.739

6.  Effects of nitric oxide on antral motility and gastric emptying in humans.

Authors:  J W Konturek; P Thor; W Domschke
Journal:  Eur J Gastroenterol Hepatol       Date:  1995-02       Impact factor: 2.566

7.  Co-localization of NOS and NMDA receptor in esophageal premotor neurons of the rat.

Authors:  D L Broussard; X Bao; X Li; S M Altschuler
Journal:  Neuroreport       Date:  1995-10-23       Impact factor: 1.837

8.  Role of nitric oxide in gastroduodenal alkaline secretion.

Authors:  J Bilski; S J Konturek
Journal:  J Physiol Pharmacol       Date:  1994-12       Impact factor: 3.011

9.  Gastric distention: a mechanism for postprandial gastroesophageal reflux.

Authors:  R H Holloway; M Hongo; K Berger; R W McCallum
Journal:  Gastroenterology       Date:  1985-10       Impact factor: 22.682

10.  Effects of nitroglycerin on liquid gastric emptying and antropyloroduodenal motility.

Authors:  W M Sun; S Doran; K L Jones; E Ooi; G Boeckxstaens; G S Hebbard; T Lingenfelser; J E Morley; J Dent; M Horowitz
Journal:  Am J Physiol       Date:  1998-11
View more
  10 in total

1.  Is glutamate involved in transient lower esophageal sphincter relaxations?

Authors:  D P Hirsch; G N J Tytgat; G E E Boeckxstaens
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

2.  Beyond acid suppression: new pharmacologic approaches for treatment of GERD.

Authors:  Paul Kuo; Richard H Holloway
Journal:  Curr Gastroenterol Rep       Date:  2010-06

3.  Effects and mechanisms of electroacupuncture at PC6 on frequency of transient lower esophageal sphincter relaxation in cats.

Authors:  Chi Wang; De-Feng Zhou; Xiao-Wei Shuai; Jian-Xiang Liu; Peng-Yan Xie
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

Review 4.  Neuro-regulation of lower esophageal sphincter function as treatment for gastroesophageal reflux disease.

Authors:  Anupender Singh Sidhu; George Triadafilopoulos
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

5.  Role of nitric oxide in gastric motor and sensory functions in healthy subjects.

Authors:  S D Kuiken; M Vergeer; S H Heisterkamp; G N J Tytgat; G E E Boeckxstaens
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

Review 6.  Gastroesophageal reflux disease and baclofen: is there a light at the end of the tunnel?

Authors:  James Wise; Jeffrey L Conklin
Journal:  Curr Gastroenterol Rep       Date:  2004-06

Review 7.  Progress with novel pharmacological strategies for gastro-oesophageal reflux disease.

Authors:  Marcello Tonini; Roberto De Giorgio; Fabrizio De Ponti
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Relationship between motor function of the proximal stomach and transient lower oesophageal sphincter relaxation after morphine.

Authors:  R Penagini; M Allocca; P Cantù; M Mangano; D Savojardo; S Carmagnola; P A Bianchi
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

9.  Investigation of cholecystokinin receptors in the human lower esophageal sphincter.

Authors:  Jun-Feng Liu; Jian Zhang; Xin-Bo Liu; Paul A Drew
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

10.  Nitric oxide-an endogenous inhibitor of gastric acid secretion in isolated human gastric glands.

Authors:  Anna Berg; Stefan Redeen; Ann-Charlott Ericson; Sven Erik Sjöstrand
Journal:  BMC Gastroenterol       Date:  2004-08-06       Impact factor: 3.067

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.